Andrew has previously worked as a consultant for UnitedHealth Group’s (UHG) OptumInsight Commercial Consulting division. He has supported pharmaceutical, payer, and provider clients in a wide variety of engagements including market access, competitive landscaping, drug pricing, and Medicare value-based arrangements. Prior to joining UHG, Andrew spent time at Merck and other biopharmaceutical firms as a drug development chemist.
Andrew’s experience includes:
- Market access strategy
- Clinical intervention design
- Provider education
- Patient education
- Strategic pricing
- Real world evidence generation
- Program management
